NOVARTIS | MATRU-SMRITI TRADERS | NOVARTIS/ MATRU-SMRITI TRADERS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 26.8 | 13.6 | 196.6% | View Chart |
P/BV | x | 3.3 | 1.0 | 334.0% | View Chart |
Dividend Yield | % | 4.6 | 0.1 | 5,690.8% |
NOVARTIS MATRU-SMRITI TRADERS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
MATRU-SMRITI TRADERS Mar-23 |
NOVARTIS/ MATRU-SMRITI TRADERS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 200 | 381.6% | |
Low | Rs | 554 | 74 | 748.6% | |
Sales per share (Unadj.) | Rs | 153.4 | 1,338.5 | 11.5% | |
Earnings per share (Unadj.) | Rs | 41.9 | 12.7 | 329.4% | |
Cash flow per share (Unadj.) | Rs | 44.3 | 13.7 | 323.5% | |
Dividends per share (Unadj.) | Rs | 47.50 | 0.10 | 47,500.0% | |
Avg Dividend yield | % | 7.2 | 0.1 | 9,880.4% | |
Book value per share (Unadj.) | Rs | 314.2 | 125.7 | 250.0% | |
Shares outstanding (eoy) | m | 24.69 | 13.95 | 177.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 0.1 | 4,195.0% | |
Avg P/E ratio | x | 15.7 | 10.8 | 146.0% | |
P/CF ratio (eoy) | x | 14.9 | 10.0 | 148.6% | |
Price / Book Value ratio | x | 2.1 | 1.1 | 192.3% | |
Dividend payout | % | 113.5 | 0.8 | 14,421.5% | |
Avg Mkt Cap | Rs m | 16,262 | 1,911 | 850.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 49 | 730.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 18,672 | 20.3% | |
Other income | Rs m | 581 | 102 | 572.5% | |
Total revenues | Rs m | 4,369 | 18,774 | 23.3% | |
Gross profit | Rs m | 651 | 143 | 454.4% | |
Depreciation | Rs m | 61 | 14 | 440.1% | |
Interest | Rs m | 18 | 47 | 37.2% | |
Profit before tax | Rs m | 1,154 | 184 | 627.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 7 | 1,826.7% | |
Profit after tax | Rs m | 1,034 | 177 | 583.0% | |
Gross profit margin | % | 17.2 | 0.8 | 2,240.5% | |
Effective tax rate | % | 10.4 | 3.6 | 291.2% | |
Net profit margin | % | 27.3 | 0.9 | 2,874.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 3,059 | 257.0% | |
Current liabilities | Rs m | 2,683 | 1,217 | 220.4% | |
Net working cap to sales | % | 136.7 | 9.9 | 1,385.8% | |
Current ratio | x | 2.9 | 2.5 | 116.6% | |
Inventory Days | Days | 1,201 | 2 | 58,888.3% | |
Debtors Days | Days | 35 | 292 | 11.9% | |
Net fixed assets | Rs m | 12,656 | 32 | 39,936.6% | |
Share capital | Rs m | 123 | 140 | 88.5% | |
"Free" reserves | Rs m | 7,634 | 1,614 | 473.0% | |
Net worth | Rs m | 7,757 | 1,753 | 442.4% | |
Long term debt | Rs m | 0 | 15 | 0.0% | |
Total assets | Rs m | 20,517 | 3,091 | 663.8% | |
Interest coverage | x | 66.9 | 4.9 | 1,363.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.2 | 6.0 | 3.1% | |
Return on assets | % | 5.1 | 7.3 | 70.6% | |
Return on equity | % | 13.3 | 10.1 | 131.8% | |
Return on capital | % | 15.1 | 13.1 | 115.6% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | -251 | -178.4% | |
From Investments | Rs m | -1,533 | 274 | -559.8% | |
From Financial Activity | Rs m | -305 | -441 | 69.1% | |
Net Cashflow | Rs m | -1,389 | -419 | 331.8% |
Indian Promoters | % | 0.0 | 74.6 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 9.8 | 7.2% | |
FIIs | % | 0.2 | 9.8 | 1.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 25.4 | 115.3% | |
Shareholders | 41,239 | 1,647 | 2,503.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA OPTIEMUS INFRACOM
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | MATRU-SMRITI TRADERS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.66% | -1.51% | -0.44% |
1-Month | -0.19% | 2.52% | -0.19% |
1-Year | 74.24% | -24.85% | 53.63% |
3-Year CAGR | 16.86% | 6.54% | 14.59% |
5-Year CAGR | 8.40% | 26.09% | 19.77% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the MATRU-SMRITI TRADERS share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of MATRU-SMRITI TRADERS the stake stands at 74.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of MATRU-SMRITI TRADERS.
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
MATRU-SMRITI TRADERS paid Rs 0.1, and its dividend payout ratio stood at 0.8%.
You may visit here to review the dividend history of Novartis, and the dividend history of MATRU-SMRITI TRADERS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.